RE:RE:Green on a red day
I fully agree on that , its just after a long time we have seen some consistent performance. Generally they need like 7mn for yearly operations , not sure how much more clinical trial will add to this. It would be gamechanging if they come up with revenue from serology testing, in my communication with CEO , he mentioned they are trying to achieve something better than existing antibody tests, so if they are hoping for acrredtion i hope they have achieved it by now. Also If they haven't already brokered a deal for revenue from this test, its kind of too late unless govt steps in kindof advise public to cater to these tests